uniQure
QURE
$4.95
Share price
5.77%
Change (1 day)
-75.97%
Change (1 year)
uniQure (QURE) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.62 B
According to uniQure's latest financial reports the company's total liabilities are $0.62 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
uniQure - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 172.55% |
| 2022-12-31 | $0.22 B | 7.29% |
| 2021-12-31 | $0.21 B | 121.17% |
| 2020-12-31 | $96.49 M | -23.16% |
| 2019-12-31 | $0.12 B | 33.16% |
| 2018-12-31 | $94.3 M | -21.6% |
| 2017-12-31 | $0.12 B | -5.01% |
| 2016-12-31 | $0.12 B | -6.01% |
| 2015-12-31 | $0.13 B | 110.24% |
| 2014-12-31 | $64.08 M | 38.93% |
| 2013-12-31 | $46.12 M | 479.87% |
| 2012-12-31 | $7.95 M | -26.91% |
| 2011-12-31 | $10.88 M | -9.52% |
| 2010-12-31 | $12.02 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $87.95 B | 14,011.75% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 9,143.28% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $72.26 M | -88.41% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.39 B | -37.26% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.79 B | 188.60% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.12 B | -80.66% | 🇺🇸 USA |